nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A4—type 2 diabetes mellitus	0.175	1	CbGaD
Alprazolam—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0362	0.0695	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0362	0.0695	CbGbCtD
Alprazolam—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0332	0.0638	CbGbCtD
Alprazolam—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0304	0.0583	CbGbCtD
Alprazolam—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0282	0.0542	CbGbCtD
Alprazolam—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0271	0.0521	CbGbCtD
Alprazolam—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.024	0.0461	CbGbCtD
Alprazolam—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.024	0.0461	CbGbCtD
Alprazolam—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0221	0.0426	CbGbCtD
Alprazolam—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0217	0.0416	CbGbCtD
Alprazolam—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0214	0.0411	CbGbCtD
Alprazolam—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0196	0.0376	CbGbCtD
Alprazolam—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0193	0.0371	CbGbCtD
Alprazolam—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0182	0.035	CbGbCtD
Alprazolam—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0177	0.0339	CbGbCtD
Alprazolam—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0174	0.0335	CbGbCtD
Alprazolam—CYP3A5—Losartan—type 2 diabetes mellitus	0.0168	0.0322	CbGbCtD
Alprazolam—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0154	0.0297	CbGbCtD
Alprazolam—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.014	0.0268	CbGbCtD
Alprazolam—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0123	0.0236	CbGbCtD
Alprazolam—CYP2C9—Losartan—type 2 diabetes mellitus	0.0112	0.0216	CbGbCtD
Alprazolam—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0106	0.0203	CbGbCtD
Alprazolam—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0101	0.0195	CbGbCtD
Alprazolam—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0101	0.0195	CbGbCtD
Alprazolam—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00959	0.0184	CbGbCtD
Alprazolam—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00714	0.0137	CbGbCtD
Alprazolam—CYP3A4—Losartan—type 2 diabetes mellitus	0.00653	0.0126	CbGbCtD
Alprazolam—Clonazepam—CYP2E1—type 2 diabetes mellitus	0.000176	0.0588	CrCbGaD
Alprazolam—Loxapine—ADRA2A—type 2 diabetes mellitus	0.000145	0.0485	CrCbGaD
Alprazolam—Flunitrazepam—CYP2E1—type 2 diabetes mellitus	0.000142	0.0472	CrCbGaD
Alprazolam—Ketazolam—CYP3A4—type 2 diabetes mellitus	0.000138	0.046	CrCbGaD
Alprazolam—Flunitrazepam—CYP1A2—type 2 diabetes mellitus	0.000135	0.0449	CrCbGaD
Alprazolam—Loxapine—HTR2C—type 2 diabetes mellitus	0.000134	0.0447	CrCbGaD
Alprazolam—Nitrazepam—CYP2E1—type 2 diabetes mellitus	0.000128	0.0426	CrCbGaD
Alprazolam—Ketazolam—ALB—type 2 diabetes mellitus	0.00012	0.0401	CrCbGaD
Alprazolam—Chlordiazepoxide—CYP3A4—type 2 diabetes mellitus	0.000115	0.0384	CrCbGaD
Alprazolam—Flurazepam—CYP2E1—type 2 diabetes mellitus	0.000114	0.0379	CrCbGaD
Alprazolam—Oedema—Metformin—type 2 diabetes mellitus	0.000114	0.000491	CcSEcCtD
Alprazolam—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000114	0.000491	CcSEcCtD
Alprazolam—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000113	0.00049	CcSEcCtD
Alprazolam—Angioedema—Losartan—type 2 diabetes mellitus	0.000113	0.000489	CcSEcCtD
Alprazolam—Infection—Metformin—type 2 diabetes mellitus	0.000113	0.000488	CcSEcCtD
Alprazolam—Insomnia—Valsartan—type 2 diabetes mellitus	0.000113	0.000488	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000112	0.000486	CcSEcCtD
Alprazolam—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000112	0.000485	CcSEcCtD
Alprazolam—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000112	0.000484	CcSEcCtD
Alprazolam—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000112	0.000484	CcSEcCtD
Alprazolam—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000484	CcSEcCtD
Alprazolam—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000484	CcSEcCtD
Alprazolam—Shock—Metformin—type 2 diabetes mellitus	0.000112	0.000483	CcSEcCtD
Alprazolam—Insomnia—Orlistat—type 2 diabetes mellitus	0.000112	0.000482	CcSEcCtD
Alprazolam—Malaise—Losartan—type 2 diabetes mellitus	0.000112	0.000482	CcSEcCtD
Alprazolam—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000112	0.000482	CcSEcCtD
Alprazolam—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000111	0.000482	CcSEcCtD
Alprazolam—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000111	0.000482	CcSEcCtD
Alprazolam—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000111	0.000481	CcSEcCtD
Alprazolam—Clonazepam—CYP3A4—type 2 diabetes mellitus	0.000111	0.037	CrCbGaD
Alprazolam—Vertigo—Losartan—type 2 diabetes mellitus	0.000111	0.00048	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000111	0.00048	CcSEcCtD
Alprazolam—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000111	0.00048	CcSEcCtD
Alprazolam—Somnolence—Valsartan—type 2 diabetes mellitus	0.000111	0.00048	CcSEcCtD
Alprazolam—Syncope—Losartan—type 2 diabetes mellitus	0.000111	0.00048	CcSEcCtD
Alprazolam—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000111	0.000479	CcSEcCtD
Alprazolam—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000111	0.000478	CcSEcCtD
Alprazolam—Skin disorder—Metformin—type 2 diabetes mellitus	0.00011	0.000477	CcSEcCtD
Alprazolam—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00011	0.000475	CcSEcCtD
Alprazolam—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00011	0.000475	CcSEcCtD
Alprazolam—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000475	CcSEcCtD
Alprazolam—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000473	CcSEcCtD
Alprazolam—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000109	0.000473	CcSEcCtD
Alprazolam—Palpitations—Losartan—type 2 diabetes mellitus	0.000109	0.000473	CcSEcCtD
Alprazolam—Nausea—Glimepiride—type 2 diabetes mellitus	0.000109	0.000471	CcSEcCtD
Alprazolam—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000109	0.00047	CcSEcCtD
Alprazolam—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000109	0.00047	CcSEcCtD
Alprazolam—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000109	0.000469	CcSEcCtD
Alprazolam—Asthenia—Glyburide—type 2 diabetes mellitus	0.000109	0.000469	CcSEcCtD
Alprazolam—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000109	0.000469	CcSEcCtD
Alprazolam—Anorexia—Metformin—type 2 diabetes mellitus	0.000108	0.000468	CcSEcCtD
Alprazolam—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000108	0.000467	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000108	0.000466	CcSEcCtD
Alprazolam—Clorazepate—CYP3A4—type 2 diabetes mellitus	0.000108	0.0359	CrCbGaD
Alprazolam—Fatigue—Valsartan—type 2 diabetes mellitus	0.000108	0.000465	CcSEcCtD
Alprazolam—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000107	0.000464	CcSEcCtD
Alprazolam—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000107	0.000464	CcSEcCtD
Alprazolam—Oedema—Irbesartan—type 2 diabetes mellitus	0.000107	0.000464	CcSEcCtD
Alprazolam—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000107	0.000464	CcSEcCtD
Alprazolam—Pruritus—Glyburide—type 2 diabetes mellitus	0.000107	0.000463	CcSEcCtD
Alprazolam—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000107	0.000461	CcSEcCtD
Alprazolam—Constipation—Valsartan—type 2 diabetes mellitus	0.000107	0.000461	CcSEcCtD
Alprazolam—Infection—Irbesartan—type 2 diabetes mellitus	0.000107	0.000461	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000106	0.00046	CcSEcCtD
Alprazolam—Fatigue—Orlistat—type 2 diabetes mellitus	0.000106	0.00046	CcSEcCtD
Alprazolam—Hypotension—Metformin—type 2 diabetes mellitus	0.000106	0.000459	CcSEcCtD
Alprazolam—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000106	0.000459	CcSEcCtD
Alprazolam—Shock—Irbesartan—type 2 diabetes mellitus	0.000106	0.000456	CcSEcCtD
Alprazolam—Midazolam—CYP2E1—type 2 diabetes mellitus	0.000105	0.0351	CrCbGaD
Alprazolam—Myalgia—Losartan—type 2 diabetes mellitus	0.000105	0.000455	CcSEcCtD
Alprazolam—Arthralgia—Losartan—type 2 diabetes mellitus	0.000105	0.000455	CcSEcCtD
Alprazolam—Chest pain—Losartan—type 2 diabetes mellitus	0.000105	0.000455	CcSEcCtD
Alprazolam—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000455	CcSEcCtD
Alprazolam—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000105	0.000455	CcSEcCtD
Alprazolam—Anxiety—Losartan—type 2 diabetes mellitus	0.000105	0.000454	CcSEcCtD
Alprazolam—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000453	CcSEcCtD
Alprazolam—Rash—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000451	CcSEcCtD
Alprazolam—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000451	CcSEcCtD
Alprazolam—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.00045	CcSEcCtD
Alprazolam—Tension—Ramipril—type 2 diabetes mellitus	0.000104	0.00045	CcSEcCtD
Alprazolam—Discomfort—Losartan—type 2 diabetes mellitus	0.000104	0.00045	CcSEcCtD
Alprazolam—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Alprazolam—Headache—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Alprazolam—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Alprazolam—Nervousness—Ramipril—type 2 diabetes mellitus	0.000103	0.000445	CcSEcCtD
Alprazolam—Dry mouth—Losartan—type 2 diabetes mellitus	0.000103	0.000445	CcSEcCtD
Alprazolam—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000442	CcSEcCtD
Alprazolam—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000102	0.000441	CcSEcCtD
Alprazolam—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000102	0.000441	CcSEcCtD
Alprazolam—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000102	0.000441	CcSEcCtD
Alprazolam—Confusional state—Losartan—type 2 diabetes mellitus	0.000102	0.00044	CcSEcCtD
Alprazolam—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000102	0.000439	CcSEcCtD
Alprazolam—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000101	0.000438	CcSEcCtD
Alprazolam—Somnolence—Metformin—type 2 diabetes mellitus	0.000101	0.000437	CcSEcCtD
Alprazolam—Oedema—Losartan—type 2 diabetes mellitus	0.000101	0.000436	CcSEcCtD
Alprazolam—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000101	0.000436	CcSEcCtD
Alprazolam—Infection—Losartan—type 2 diabetes mellitus	0.0001	0.000434	CcSEcCtD
Alprazolam—Hypotension—Irbesartan—type 2 diabetes mellitus	0.0001	0.000433	CcSEcCtD
Alprazolam—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0001	0.000433	CcSEcCtD
Alprazolam—Dyspepsia—Metformin—type 2 diabetes mellitus	0.0001	0.000433	CcSEcCtD
Alprazolam—Tremor—Ramipril—type 2 diabetes mellitus	9.94e-05	0.00043	CcSEcCtD
Alprazolam—Shock—Losartan—type 2 diabetes mellitus	9.93e-05	0.000429	CcSEcCtD
Alprazolam—Urticaria—Valsartan—type 2 diabetes mellitus	9.92e-05	0.000429	CcSEcCtD
Alprazolam—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.9e-05	0.000428	CcSEcCtD
Alprazolam—Decreased appetite—Metformin—type 2 diabetes mellitus	9.88e-05	0.000427	CcSEcCtD
Alprazolam—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.87e-05	0.000427	CcSEcCtD
Alprazolam—Tachycardia—Losartan—type 2 diabetes mellitus	9.85e-05	0.000426	CcSEcCtD
Alprazolam—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.84e-05	0.000425	CcSEcCtD
Alprazolam—Nausea—Bromocriptine—type 2 diabetes mellitus	9.83e-05	0.000425	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.81e-05	0.000424	CcSEcCtD
Alprazolam—Fatigue—Metformin—type 2 diabetes mellitus	9.8e-05	0.000424	CcSEcCtD
Alprazolam—Urticaria—Orlistat—type 2 diabetes mellitus	9.8e-05	0.000424	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.77e-05	0.000423	CcSEcCtD
Alprazolam—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.76e-05	0.000422	CcSEcCtD
Alprazolam—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.75e-05	0.000422	CcSEcCtD
Alprazolam—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.75e-05	0.000422	CcSEcCtD
Alprazolam—Asthenia—Gliclazide—type 2 diabetes mellitus	9.75e-05	0.000421	CcSEcCtD
Alprazolam—Agitation—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000421	CcSEcCtD
Alprazolam—Clobazam—CYP3A4—type 2 diabetes mellitus	9.74e-05	0.0325	CrCbGaD
Alprazolam—Constipation—Metformin—type 2 diabetes mellitus	9.72e-05	0.00042	CcSEcCtD
Alprazolam—Clonazepam—ALB—type 2 diabetes mellitus	9.69e-05	0.0323	CrCbGaD
Alprazolam—Angioedema—Ramipril—type 2 diabetes mellitus	9.69e-05	0.000419	CcSEcCtD
Alprazolam—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.000416	CcSEcCtD
Alprazolam—Anorexia—Losartan—type 2 diabetes mellitus	9.62e-05	0.000416	CcSEcCtD
Alprazolam—Vomiting—Glyburide—type 2 diabetes mellitus	9.62e-05	0.000416	CcSEcCtD
Alprazolam—Pruritus—Gliclazide—type 2 diabetes mellitus	9.61e-05	0.000416	CcSEcCtD
Alprazolam—Malaise—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000413	CcSEcCtD
Alprazolam—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000413	CcSEcCtD
Alprazolam—Rash—Glyburide—type 2 diabetes mellitus	9.54e-05	0.000412	CcSEcCtD
Alprazolam—Somnolence—Irbesartan—type 2 diabetes mellitus	9.54e-05	0.000412	CcSEcCtD
Alprazolam—Dermatitis—Glyburide—type 2 diabetes mellitus	9.53e-05	0.000412	CcSEcCtD
Alprazolam—Vertigo—Ramipril—type 2 diabetes mellitus	9.53e-05	0.000412	CcSEcCtD
Alprazolam—Syncope—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000411	CcSEcCtD
Alprazolam—Headache—Glyburide—type 2 diabetes mellitus	9.48e-05	0.00041	CcSEcCtD
Alprazolam—Quazepam—CYP3A4—type 2 diabetes mellitus	9.45e-05	0.0315	CrCbGaD
Alprazolam—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.44e-05	0.000408	CcSEcCtD
Alprazolam—Hypotension—Losartan—type 2 diabetes mellitus	9.43e-05	0.000408	CcSEcCtD
Alprazolam—Palpitations—Ramipril—type 2 diabetes mellitus	9.37e-05	0.000405	CcSEcCtD
Alprazolam—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.37e-05	0.000405	CcSEcCtD
Alprazolam—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.32e-05	0.000403	CcSEcCtD
Alprazolam—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.32e-05	0.000403	CcSEcCtD
Alprazolam—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.3e-05	0.000402	CcSEcCtD
Alprazolam—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.29e-05	0.000402	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.0004	CcSEcCtD
Alprazolam—Fatigue—Irbesartan—type 2 diabetes mellitus	9.25e-05	0.0004	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.2e-05	0.000398	CcSEcCtD
Alprazolam—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.2e-05	0.000398	CcSEcCtD
Alprazolam—Convulsion—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000397	CcSEcCtD
Alprazolam—Constipation—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000397	CcSEcCtD
Alprazolam—Insomnia—Losartan—type 2 diabetes mellitus	9.13e-05	0.000395	CcSEcCtD
Alprazolam—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.09e-05	0.000393	CcSEcCtD
Alprazolam—Paraesthesia—Losartan—type 2 diabetes mellitus	9.06e-05	0.000392	CcSEcCtD
Alprazolam—Diazepam—CYP2E1—type 2 diabetes mellitus	9.03e-05	0.0301	CrCbGaD
Alprazolam—Urticaria—Metformin—type 2 diabetes mellitus	9.03e-05	0.00039	CcSEcCtD
Alprazolam—Chest pain—Ramipril—type 2 diabetes mellitus	9.03e-05	0.00039	CcSEcCtD
Alprazolam—Myalgia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.00039	CcSEcCtD
Alprazolam—Arthralgia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.00039	CcSEcCtD
Alprazolam—Dyspnoea—Losartan—type 2 diabetes mellitus	9e-05	0.000389	CcSEcCtD
Alprazolam—Anxiety—Ramipril—type 2 diabetes mellitus	9e-05	0.000389	CcSEcCtD
Alprazolam—Nausea—Glyburide—type 2 diabetes mellitus	8.99e-05	0.000389	CcSEcCtD
Alprazolam—Abdominal pain—Metformin—type 2 diabetes mellitus	8.99e-05	0.000388	CcSEcCtD
Alprazolam—Dizziness—Gliclazide—type 2 diabetes mellitus	8.98e-05	0.000388	CcSEcCtD
Alprazolam—Somnolence—Losartan—type 2 diabetes mellitus	8.97e-05	0.000388	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.97e-05	0.000388	CcSEcCtD
Alprazolam—Asthenia—Valsartan—type 2 diabetes mellitus	8.96e-05	0.000387	CcSEcCtD
Alprazolam—Flunitrazepam—CYP3A4—type 2 diabetes mellitus	8.92e-05	0.0297	CrCbGaD
Alprazolam—Discomfort—Ramipril—type 2 diabetes mellitus	8.92e-05	0.000386	CcSEcCtD
Alprazolam—Dyspepsia—Losartan—type 2 diabetes mellitus	8.89e-05	0.000384	CcSEcCtD
Alprazolam—Asthenia—Orlistat—type 2 diabetes mellitus	8.85e-05	0.000383	CcSEcCtD
Alprazolam—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.84e-05	0.000382	CcSEcCtD
Alprazolam—Pruritus—Valsartan—type 2 diabetes mellitus	8.83e-05	0.000382	CcSEcCtD
Alprazolam—Dry mouth—Ramipril—type 2 diabetes mellitus	8.83e-05	0.000382	CcSEcCtD
Alprazolam—Decreased appetite—Losartan—type 2 diabetes mellitus	8.78e-05	0.000379	CcSEcCtD
Alprazolam—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.000379	CcSEcCtD
Alprazolam—Confusional state—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000377	CcSEcCtD
Alprazolam—Pruritus—Orlistat—type 2 diabetes mellitus	8.73e-05	0.000377	CcSEcCtD
Alprazolam—Fatigue—Losartan—type 2 diabetes mellitus	8.7e-05	0.000376	CcSEcCtD
Alprazolam—Oedema—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000374	CcSEcCtD
Alprazolam—Vomiting—Gliclazide—type 2 diabetes mellitus	8.64e-05	0.000373	CcSEcCtD
Alprazolam—Constipation—Losartan—type 2 diabetes mellitus	8.63e-05	0.000373	CcSEcCtD
Alprazolam—Diazepam—CYP1A2—type 2 diabetes mellitus	8.59e-05	0.0286	CrCbGaD
Alprazolam—Rash—Gliclazide—type 2 diabetes mellitus	8.57e-05	0.00037	CcSEcCtD
Alprazolam—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.56e-05	0.00037	CcSEcCtD
Alprazolam—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.54e-05	0.000369	CcSEcCtD
Alprazolam—Urticaria—Irbesartan—type 2 diabetes mellitus	8.52e-05	0.000368	CcSEcCtD
Alprazolam—Shock—Ramipril—type 2 diabetes mellitus	8.52e-05	0.000368	CcSEcCtD
Alprazolam—Headache—Gliclazide—type 2 diabetes mellitus	8.51e-05	0.000368	CcSEcCtD
Alprazolam—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000367	CcSEcCtD
Alprazolam—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000367	CcSEcCtD
Alprazolam—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000367	CcSEcCtD
Alprazolam—Tachycardia—Ramipril—type 2 diabetes mellitus	8.45e-05	0.000365	CcSEcCtD
Alprazolam—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.44e-05	0.000365	CcSEcCtD
Alprazolam—Skin disorder—Ramipril—type 2 diabetes mellitus	8.41e-05	0.000363	CcSEcCtD
Alprazolam—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000362	CcSEcCtD
Alprazolam—Estazolam—CYP3A4—type 2 diabetes mellitus	8.35e-05	0.0278	CrCbGaD
Alprazolam—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.32e-05	0.00036	CcSEcCtD
Alprazolam—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.25e-05	0.000357	CcSEcCtD
Alprazolam—Dizziness—Valsartan—type 2 diabetes mellitus	8.25e-05	0.000357	CcSEcCtD
Alprazolam—Anorexia—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000357	CcSEcCtD
Alprazolam—Dizziness—Orlistat—type 2 diabetes mellitus	8.16e-05	0.000353	CcSEcCtD
Alprazolam—Asthenia—Metformin—type 2 diabetes mellitus	8.16e-05	0.000353	CcSEcCtD
Alprazolam—Hypotension—Ramipril—type 2 diabetes mellitus	8.09e-05	0.00035	CcSEcCtD
Alprazolam—Nausea—Gliclazide—type 2 diabetes mellitus	8.07e-05	0.000349	CcSEcCtD
Alprazolam—Nitrazepam—CYP3A4—type 2 diabetes mellitus	8.05e-05	0.0269	CrCbGaD
Alprazolam—Pruritus—Metformin—type 2 diabetes mellitus	8.04e-05	0.000348	CcSEcCtD
Alprazolam—Urticaria—Losartan—type 2 diabetes mellitus	8.02e-05	0.000347	CcSEcCtD
Alprazolam—Abdominal pain—Losartan—type 2 diabetes mellitus	7.98e-05	0.000345	CcSEcCtD
Alprazolam—Body temperature increased—Losartan—type 2 diabetes mellitus	7.98e-05	0.000345	CcSEcCtD
Alprazolam—Adinazolam—CYP3A4—type 2 diabetes mellitus	7.94e-05	0.0265	CrCbGaD
Alprazolam—Vomiting—Valsartan—type 2 diabetes mellitus	7.94e-05	0.000343	CcSEcCtD
Alprazolam—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000342	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.89e-05	0.000341	CcSEcCtD
Alprazolam—Rash—Valsartan—type 2 diabetes mellitus	7.87e-05	0.00034	CcSEcCtD
Alprazolam—Dermatitis—Valsartan—type 2 diabetes mellitus	7.86e-05	0.00034	CcSEcCtD
Alprazolam—Vomiting—Orlistat—type 2 diabetes mellitus	7.84e-05	0.000339	CcSEcCtD
Alprazolam—Insomnia—Ramipril—type 2 diabetes mellitus	7.83e-05	0.000338	CcSEcCtD
Alprazolam—Headache—Valsartan—type 2 diabetes mellitus	7.82e-05	0.000338	CcSEcCtD
Alprazolam—Diarrhoea—Metformin—type 2 diabetes mellitus	7.78e-05	0.000336	CcSEcCtD
Alprazolam—Rash—Orlistat—type 2 diabetes mellitus	7.78e-05	0.000336	CcSEcCtD
Alprazolam—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000336	CcSEcCtD
Alprazolam—Dermatitis—Orlistat—type 2 diabetes mellitus	7.77e-05	0.000336	CcSEcCtD
Alprazolam—Headache—Orlistat—type 2 diabetes mellitus	7.73e-05	0.000334	CcSEcCtD
Alprazolam—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000334	CcSEcCtD
Alprazolam—Asthenia—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000333	CcSEcCtD
Alprazolam—Somnolence—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000333	CcSEcCtD
Alprazolam—Prazepam—CYP3A4—type 2 diabetes mellitus	7.68e-05	0.0256	CrCbGaD
Alprazolam—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000329	CcSEcCtD
Alprazolam—Pruritus—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000328	CcSEcCtD
Alprazolam—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000325	CcSEcCtD
Alprazolam—Dizziness—Metformin—type 2 diabetes mellitus	7.52e-05	0.000325	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000323	CcSEcCtD
Alprazolam—Fatigue—Ramipril—type 2 diabetes mellitus	7.46e-05	0.000323	CcSEcCtD
Alprazolam—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.44e-05	0.000322	CcSEcCtD
Alprazolam—Nausea—Valsartan—type 2 diabetes mellitus	7.41e-05	0.000321	CcSEcCtD
Alprazolam—Constipation—Ramipril—type 2 diabetes mellitus	7.4e-05	0.00032	CcSEcCtD
Alprazolam—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.000317	CcSEcCtD
Alprazolam—Nausea—Orlistat—type 2 diabetes mellitus	7.33e-05	0.000317	CcSEcCtD
Alprazolam—Asthenia—Losartan—type 2 diabetes mellitus	7.24e-05	0.000313	CcSEcCtD
Alprazolam—Vomiting—Metformin—type 2 diabetes mellitus	7.23e-05	0.000312	CcSEcCtD
Alprazolam—Rash—Metformin—type 2 diabetes mellitus	7.17e-05	0.00031	CcSEcCtD
Alprazolam—Flurazepam—CYP3A4—type 2 diabetes mellitus	7.16e-05	0.0239	CrCbGaD
Alprazolam—Dermatitis—Metformin—type 2 diabetes mellitus	7.16e-05	0.00031	CcSEcCtD
Alprazolam—Triazolam—CYP3A4—type 2 diabetes mellitus	7.15e-05	0.0238	CrCbGaD
Alprazolam—Pruritus—Losartan—type 2 diabetes mellitus	7.14e-05	0.000309	CcSEcCtD
Alprazolam—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.13e-05	0.000308	CcSEcCtD
Alprazolam—Headache—Metformin—type 2 diabetes mellitus	7.12e-05	0.000308	CcSEcCtD
Alprazolam—Dizziness—Irbesartan—type 2 diabetes mellitus	7.09e-05	0.000307	CcSEcCtD
Alprazolam—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000306	CcSEcCtD
Alprazolam—Oxazepam—CYP3A4—type 2 diabetes mellitus	6.94e-05	0.0231	CrCbGaD
Alprazolam—Diarrhoea—Losartan—type 2 diabetes mellitus	6.91e-05	0.000299	CcSEcCtD
Alprazolam—Urticaria—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000297	CcSEcCtD
Alprazolam—Temazepam—CYP3A4—type 2 diabetes mellitus	6.85e-05	0.0228	CrCbGaD
Alprazolam—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000296	CcSEcCtD
Alprazolam—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000296	CcSEcCtD
Alprazolam—Vomiting—Irbesartan—type 2 diabetes mellitus	6.82e-05	0.000295	CcSEcCtD
Alprazolam—Rash—Irbesartan—type 2 diabetes mellitus	6.76e-05	0.000292	CcSEcCtD
Alprazolam—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.76e-05	0.000292	CcSEcCtD
Alprazolam—Nausea—Metformin—type 2 diabetes mellitus	6.75e-05	0.000292	CcSEcCtD
Alprazolam—Headache—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.000291	CcSEcCtD
Alprazolam—Dizziness—Losartan—type 2 diabetes mellitus	6.68e-05	0.000289	CcSEcCtD
Alprazolam—Midazolam—CYP3A4—type 2 diabetes mellitus	6.64e-05	0.0221	CrCbGaD
Alprazolam—Vomiting—Losartan—type 2 diabetes mellitus	6.42e-05	0.000277	CcSEcCtD
Alprazolam—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000276	CcSEcCtD
Alprazolam—Nausea—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000275	CcSEcCtD
Alprazolam—Rash—Losartan—type 2 diabetes mellitus	6.37e-05	0.000275	CcSEcCtD
Alprazolam—Dermatitis—Losartan—type 2 diabetes mellitus	6.36e-05	0.000275	CcSEcCtD
Alprazolam—Headache—Losartan—type 2 diabetes mellitus	6.32e-05	0.000273	CcSEcCtD
Alprazolam—Asthenia—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000268	CcSEcCtD
Alprazolam—Pruritus—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000265	CcSEcCtD
Alprazolam—Nausea—Losartan—type 2 diabetes mellitus	6e-05	0.000259	CcSEcCtD
Alprazolam—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000256	CcSEcCtD
Alprazolam—Dizziness—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000247	CcSEcCtD
Alprazolam—Diazepam—CYP3A4—type 2 diabetes mellitus	5.69e-05	0.019	CrCbGaD
Alprazolam—Vomiting—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000238	CcSEcCtD
Alprazolam—Rash—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000236	CcSEcCtD
Alprazolam—Dermatitis—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000236	CcSEcCtD
Alprazolam—Headache—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000234	CcSEcCtD
Alprazolam—Nausea—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000222	CcSEcCtD
Alprazolam—Diazepam—ALB—type 2 diabetes mellitus	4.96e-05	0.0165	CrCbGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.33e-05	0.000189	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LPA—type 2 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GCKR—type 2 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—KCNJ11—type 2 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HSD3B2—type 2 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SNAP25—type 2 diabetes mellitus	1.29e-05	0.000183	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PSMD6—type 2 diabetes mellitus	1.29e-05	0.000183	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SREBF1—type 2 diabetes mellitus	1.29e-05	0.000183	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	1.27e-05	0.000181	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CTGF—type 2 diabetes mellitus	1.26e-05	0.00018	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HMGCR—type 2 diabetes mellitus	1.25e-05	0.000178	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALDOB—type 2 diabetes mellitus	1.25e-05	0.000178	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ADRA2A—type 2 diabetes mellitus	1.23e-05	0.000174	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.21e-05	0.000173	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.21e-05	0.000173	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.21e-05	0.000173	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP2E1—type 2 diabetes mellitus	1.18e-05	0.000167	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.17e-05	0.000166	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.17e-05	0.000166	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.16e-05	0.000166	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.16e-05	0.000166	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1A2—type 2 diabetes mellitus	1.16e-05	0.000165	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC2A1—type 2 diabetes mellitus	1.16e-05	0.000165	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	1.16e-05	0.000165	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP3A4—type 2 diabetes mellitus	1.13e-05	0.000161	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.12e-05	0.000159	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.12e-05	0.000159	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC2A4—type 2 diabetes mellitus	1.12e-05	0.000159	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GCG—type 2 diabetes mellitus	1.12e-05	0.000159	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.11e-05	0.000158	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.11e-05	0.000158	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.1e-05	0.000157	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.1e-05	0.000156	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	1.09e-05	0.000154	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.08e-05	0.000154	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.08e-05	0.000154	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.08e-05	0.000154	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	1.06e-05	0.000151	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	1.06e-05	0.000151	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.06e-05	0.00015	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.05e-05	0.000149	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	1.04e-05	0.000148	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	1.03e-05	0.000147	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.02e-05	0.000145	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	1.01e-05	0.000144	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1e-05	0.000142	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	1e-05	0.000142	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.77e-06	0.000139	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	9.75e-06	0.000139	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	9.75e-06	0.000139	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.62e-06	0.000137	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GNB3—type 2 diabetes mellitus	9.62e-06	0.000137	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HMOX1—type 2 diabetes mellitus	9.57e-06	0.000136	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	9.53e-06	0.000135	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.52e-06	0.000135	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CAT—type 2 diabetes mellitus	9.45e-06	0.000134	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	9.42e-06	0.000134	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.42e-06	0.000134	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	9.42e-06	0.000134	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	9.42e-06	0.000134	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	9.42e-06	0.000134	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	9.3e-06	0.000132	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	9.3e-06	0.000132	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	9.3e-06	0.000132	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	9.2e-06	0.000131	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	9.2e-06	0.000131	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	9.2e-06	0.000131	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	9.2e-06	0.000131	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOB—type 2 diabetes mellitus	9.17e-06	0.00013	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	9.13e-06	0.00013	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	9.12e-06	0.00013	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	9.05e-06	0.000129	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTM1—type 2 diabetes mellitus	8.92e-06	0.000127	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	8.86e-06	0.000126	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.85e-06	0.000126	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	8.82e-06	0.000125	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	8.76e-06	0.000124	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.61e-06	0.000122	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.61e-06	0.000122	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	8.57e-06	0.000122	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.57e-06	0.000122	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	8.54e-06	0.000121	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	8.51e-06	0.000121	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	8.41e-06	0.00012	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	8.41e-06	0.00012	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.4e-06	0.000119	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	8.39e-06	0.000119	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	8.32e-06	0.000118	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.3e-06	0.000118	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	8.21e-06	0.000117	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	8.2e-06	0.000117	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	8.2e-06	0.000117	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	8.07e-06	0.000115	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	8.07e-06	0.000115	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	8.01e-06	0.000114	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	8.01e-06	0.000114	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	8.01e-06	0.000114	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	7.88e-06	0.000112	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	7.73e-06	0.00011	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.68e-06	0.000109	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.68e-06	0.000109	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	7.66e-06	0.000109	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	7.5e-06	0.000107	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	7.5e-06	0.000107	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	7.49e-06	0.000107	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.39e-06	0.000105	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.39e-06	0.000105	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	7.36e-06	0.000105	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	7.36e-06	0.000105	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	7.34e-06	0.000104	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.31e-06	0.000104	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	7.31e-06	0.000104	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	7.31e-06	0.000104	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	7.31e-06	0.000104	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	7.27e-06	0.000103	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.26e-06	0.000103	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	7.25e-06	0.000103	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.14e-06	0.000101	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.14e-06	0.000101	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.14e-06	0.000101	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	7.14e-06	0.000101	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	7.05e-06	0.0001	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	6.95e-06	9.88e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.95e-06	9.88e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	6.92e-06	9.84e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	6.83e-06	9.71e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.71e-06	9.54e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	6.63e-06	9.42e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.58e-06	9.35e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.56e-06	9.32e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.56e-06	9.32e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.56e-06	9.32e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	6.45e-06	9.17e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	6.44e-06	9.15e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	6.39e-06	9.09e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	6.38e-06	9.07e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	6.33e-06	9e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.29e-06	8.94e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.28e-06	8.94e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	6.27e-06	8.91e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	6.24e-06	8.88e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	6.2e-06	8.81e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	6.17e-06	8.78e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.07e-06	8.63e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.07e-06	8.63e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.07e-06	8.63e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.07e-06	8.63e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	6.01e-06	8.55e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	6e-06	8.53e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	5.94e-06	8.44e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.93e-06	8.43e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.93e-06	8.43e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.82e-06	8.27e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.78e-06	8.22e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.75e-06	8.18e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	5.75e-06	8.17e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	5.7e-06	8.1e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.69e-06	8.08e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.69e-06	8.08e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	5.59e-06	7.95e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	5.5e-06	7.82e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	5.5e-06	7.82e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	5.41e-06	7.7e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.41e-06	7.69e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	5.32e-06	7.57e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	5.3e-06	7.54e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	5.24e-06	7.46e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.05e-06	7.18e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	5.03e-06	7.15e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.95e-06	7.04e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.95e-06	7.04e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.9e-06	6.97e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.9e-06	6.97e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.88e-06	6.94e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.85e-06	6.9e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.82e-06	6.86e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.82e-06	6.86e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.82e-06	6.86e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.81e-06	6.84e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.79e-06	6.81e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.71e-06	6.69e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.67e-06	6.64e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.65e-06	6.61e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	4.62e-06	6.57e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.55e-06	6.46e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	4.53e-06	6.44e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.46e-06	6.34e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.37e-06	6.21e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.35e-06	6.19e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.32e-06	6.15e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.32e-06	6.15e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.32e-06	6.15e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.24e-06	6.04e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.24e-06	6.03e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.21e-06	5.98e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.19e-06	5.95e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	4.15e-06	5.91e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.12e-06	5.85e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.02e-06	5.71e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.97e-06	5.65e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.97e-06	5.65e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.96e-06	5.62e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.94e-06	5.6e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.91e-06	5.56e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.91e-06	5.56e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.82e-06	5.43e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.75e-06	5.34e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.75e-06	5.33e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.75e-06	5.33e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.74e-06	5.32e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.7e-06	5.26e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.63e-06	5.17e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.26e-06	4.63e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.23e-06	4.6e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.23e-06	4.6e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.22e-06	4.57e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.19e-06	4.54e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.17e-06	4.51e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.08e-06	4.38e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3e-06	4.26e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.94e-06	4.18e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.93e-06	4.16e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.88e-06	4.1e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.87e-06	4.08e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.8e-06	3.98e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.8e-06	3.98e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.8e-06	3.98e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.76e-06	3.93e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.65e-06	3.77e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.6e-06	3.7e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.56e-06	3.64e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	2.53e-06	3.59e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.52e-06	3.58e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.48e-06	3.52e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.47e-06	3.51e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.44e-06	3.47e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.15e-06	3.05e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.11e-06	3e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.93e-06	2.75e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.85e-06	2.63e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.85e-06	2.63e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.83e-06	2.6e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.69e-06	2.4e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.29e-06	1.83e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.49e-07	1.21e-05	CbGpPWpGaD
